Brainstorm Cell Therapeutics reported $-0.19 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
Alterity Therapeutics Limited AUD 0 0 Dec/2025
Biogen USD 3.6 0.03 Jun/2026
Brainstorm Cell Therapeutics USD -0.19 0 Mar/2026
Cipla INR 9.76 2.9 Jun/2026
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.23 0.82 Mar/2026
CSL USD 5.07 3 Dec/2025
Cytokinetics USD -1.5 0.17 Jun/2026
Gilead Sciences USD -6.75 8.78 Jun/2026
Grifols EUR 0.16 0.02 Mar/2026
Halozyme Therapeutics USD 2.28 0.68 Jun/2026
Mesoblast USD -0.03 0.01 Dec/2025